Showing results (321-330 of 349) with videos related to

Sort By:
Pageof 35
British Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteersKyoung Soo Lim, Joo-Youn Cho, Bo-Hyung Kim, et al.
The Oncologist|June 27, 2015
Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric CancerKeun-Wook Lee, Kyung Hee Lee, Dae Young Zang, et al.
Clinical Pharmacology and Therapeutics|August 4, 2004
Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic statesKyung-Sang Yu, Joo-Youn Cho, In-Jin Jang, et al.
Epilepsy & Behavior : E&B|December 17, 2020
Effects of perampanel on cognition and quantitative electroencephalography in patients with epilepsySeon-Jae Ahn, Tae-Joon Kim, Kwang Su Cha, et al.
Korean Journal of Pediatrics|December 27, 2016
Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous diseaseHee Young Ju, Hyoung Jin Kang, Che Ry Hong, et al.
Epilepsia|September 27, 2016
HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruptionJangsup Moon, Tae-Joon Kim, Jung-Ah Lim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 2011
Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modelingJi Won Lee, Hyoung Jin Kang, Seung Hwan Lee, et al.
Pageof 35